-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… agents, including cyclophosphamide, oxaliplatin, epirubicin, and … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer … small cell lung cancer patients. Lung Cancer. 2011;72 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …
-
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02 Jun 2025 16:00 GMT
… and Non-Small Cell Lung Cancer
Two presentations at the … results at ASCO. In lung cancer, patient recruitment is progressing … metastatic non-small cell lung cancer and secondary resistance to … acid, fluorouracil, irinotecan and oxaliplatin
3 Trends in the …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… and MPR.
About Lung Cancer
Lung cancer is the leading cause … treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.
OPDIVO® … metastatic non-small cell lung cancer, in combination with … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Domvanalimab-Based Combo Aims to Leverage Anti-TIGIT Mechanism in Upper GI Cancers
02 Jul 2025 13:42 GMT
… ), and FOLFOX (leucovorin, fluorouracil, and oxaliplatin) is being further evaluated in … seen multiple negative studies in lung cancer, for example; however, upper GI …
-
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Patients with Hepatocellular Carcinoma Receiving HAIC-Based Conversion Hepatectomy: A Dual-Center Retrospective Cohort Study
01 Jul 2025 22:17 GMT
… for colorectal cancer, lung cancer, melanoma, and other … arterial infusion of oxaliplatin, fluorouracil, and … Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin … cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017 …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… doxorubicin, pirarubicin, irinotecan, oxaliplatin, cisplatin, gemcitabine, etc … drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis … pathologic assessment of lung cancer resection specimens …
About
© 1995-2025